Loading
Yanuki
ARTICLE DETAIL
Medline Founding Family Worth Billions After IPO | Live Nation and Justice Department Reach Settlement in Antitrust Case | Walmart vs BJ’s Wholesale: Which Retailer Is the Better Buy? | Byron Allen Acquires Stake in Starz: What It Means for the Media Landscape | Exxon Mobil Stock Soars on Swiss Exchange Amid Record Volume | Stock Market Plunge: Sensex Tumbles as Oil Surges Amid Iran War Fears | Oil Prices Surge, Stocks Drop After Weak U.S. Job Market Update | Oil Prices Surge Amid Iran Conflict: Will Strategic Petroleum Reserve Be Tapped? | Lloyd Blankfein on Wall Street Crises: Past and Future | Medline Founding Family Worth Billions After IPO | Live Nation and Justice Department Reach Settlement in Antitrust Case | Walmart vs BJ’s Wholesale: Which Retailer Is the Better Buy? | Byron Allen Acquires Stake in Starz: What It Means for the Media Landscape | Exxon Mobil Stock Soars on Swiss Exchange Amid Record Volume | Stock Market Plunge: Sensex Tumbles as Oil Surges Amid Iran War Fears | Oil Prices Surge, Stocks Drop After Weak U.S. Job Market Update | Oil Prices Surge Amid Iran Conflict: Will Strategic Petroleum Reserve Be Tapped? | Lloyd Blankfein on Wall Street Crises: Past and Future

Business / Billionaires

Medline Founding Family Worth Billions After IPO

Medline's upcoming IPO is set to be a blockbuster, revealing the massive wealth of the Mills family, who founded the medical supplies giant in 1910. After selling a majority stake to private equity in 2021, their remaining stake is still wo...

Medical supply firm Medline targets $55 billion valuation in blockbuster IPO
Share
X LinkedIn

medline ipo
Medline Founding Family Worth Billions After IPO Image via Reuters

Key Insights

  • Medline's IPO is valued at up to $55 billion.
  • The Mills family's remaining stake is estimated at $6 billion to $7 billion.
  • Combined with the 2021 stake sale, the family's net worth is around $20 billion.
  • Medline's sales reached $25.5 billion in 2024, an 83% increase from five years prior.

In-Depth Analysis

Medline's journey began in 1910 with A.L. Mills selling butcher aprons. The company quickly pivoted to medical garments after a request from a local hospital. Over the decades, Medline pioneered innovations such as surgeon gowns with 360-degree coverage and the now-standard blue and green operating room fabrics.

In 2021, the Mills family sold a majority stake to private equity firms including Blackstone Group and Carlyle Group. This move has proven beneficial, with sales reaching $25.5 billion in 2024, an 83% increase from $13.9 billion five years earlier. Private-equity ownership appears to have spurred growth and profitability.

Medline's success can be attributed to its ability to adapt to changing market needs and its focus on providing essential medical supplies. The IPO marks a significant milestone, solidifying the Mills family's legacy and the company's position as a leader in the healthcare industry.

Read source article

FAQ

How much is the Mills family worth?

Forbes estimates their combined net worth to be $20 billion.

When did Medline sell a majority stake to private equity?

The family sold a majority stake in June 2021.

Takeaways

  • The Medline IPO highlights the significant value within the medical supplies industry.
  • Strategic partnerships with private equity firms can drive substantial growth for family-owned businesses.
  • Medline's history demonstrates the importance of innovation and adaptation in achieving long-term success.

Discussion

Do you think Medline's success will continue? Let us know!

Share this article with others who need to stay ahead of this trend!

Sources

Disclaimer

This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.

All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.

This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.

Always do your own research (DYOR) before making any decisions based on the information presented.